Yu‐Min Shen

2.1k total citations
39 papers, 554 citations indexed

About

Yu‐Min Shen is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Yu‐Min Shen has authored 39 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Immunology and 7 papers in Surgery. Recurrent topics in Yu‐Min Shen's work include Platelet Disorders and Treatments (12 papers), Complement system in diseases (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Yu‐Min Shen is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Complement system in diseases (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Yu‐Min Shen collaborates with scholars based in United States, United Kingdom and China. Yu‐Min Shen's co-authors include Ravi Sarode, Karén Matevosyan, Cynthia Rutherford, Gilbert Chu, Howard Sussman, Eugene P. Frenkel, Sean G. Yates, Gamze B. Bulut, Lily Huang and Ellen S. Vitetta and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Yu‐Min Shen

33 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Min Shen United States 11 202 142 111 99 96 39 554
Virginia Bosó Spain 16 74 0.4× 92 0.6× 118 1.1× 140 1.4× 68 0.7× 40 628
Takakazu Higuchi Japan 15 224 1.1× 71 0.5× 93 0.8× 105 1.1× 45 0.5× 55 567
Josette Champagne Canada 15 326 1.6× 288 2.0× 151 1.4× 148 1.5× 87 0.9× 26 896
Rahul Naithani India 17 380 1.9× 68 0.5× 97 0.9× 102 1.0× 27 0.3× 77 740
Lijuan Li China 14 170 0.8× 199 1.4× 169 1.5× 78 0.8× 39 0.4× 74 549
J. F. Johnson United States 16 132 0.7× 97 0.7× 264 2.4× 87 0.9× 46 0.5× 53 951
Marit Hellebostad Norway 16 413 2.0× 84 0.6× 134 1.2× 160 1.6× 39 0.4× 37 929
Neng Yu United States 19 178 0.9× 439 3.1× 105 0.9× 88 0.9× 95 1.0× 57 945
Charlotte Bradbury United Kingdom 15 308 1.5× 47 0.3× 451 4.1× 194 2.0× 63 0.7× 36 1.1k
Ahmad Naim United States 15 322 1.6× 96 0.7× 215 1.9× 99 1.0× 77 0.8× 45 781

Countries citing papers authored by Yu‐Min Shen

Since Specialization
Citations

This map shows the geographic impact of Yu‐Min Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Min Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Min Shen more than expected).

Fields of papers citing papers by Yu‐Min Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Min Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Min Shen. The network helps show where Yu‐Min Shen may publish in the future.

Co-authorship network of co-authors of Yu‐Min Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Min Shen. A scholar is included among the top collaborators of Yu‐Min Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Min Shen. Yu‐Min Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jaehyup, James Burner, Ravi Sarode, et al.. (2025). Clinical and haematological features of hyperhaemolysis in sickle cell disease: A case series from two tertiary care centres. British Journal of Haematology. 207(6). 2643–2647.
2.
3.
Shen, Yu‐Min, Zhipeng Cai, Li Zhang, et al.. (2024). Efficient Premature Ventricular Contraction Detection Based on Network Dynamics Features. IEEE Transactions on Instrumentation and Measurement. 73. 1–15. 8 indexed citations
4.
Adkins, Brian D., et al.. (2024). How do we manage hyperhemolysis syndrome. Transfusion. 64(10). 1822–1829.
5.
Yates, Sean G., et al.. (2024). Tailoring caplacizumab administration using ADAMTS13 activity for immune-mediated thrombotic thrombocytopenic purpura. PubMed. 1(3). 100010–100010. 1 indexed citations
6.
Brahma, Sanjaya, et al.. (2023). Effect of Mo-addition over a large enhancement of the hydrogen evolution reaction in WC/rGO nanocomposite. Materials Letters. 341. 134238–134238.
7.
Yates, Sean G., et al.. (2023). Bortezomib in relapsed/refractory immune thrombotic thrombocytopenic purpura: A single‐centre retrospective cohort and systematic literature review. British Journal of Haematology. 204(2). 638–643. 4 indexed citations
8.
Shen, Yu‐Min, et al.. (2023). Short Video Addiction on the Interaction of Creative Self-Efficacy and Career Interest to Innovative Design Profession Students. Healthcare. 11(4). 579–579. 15 indexed citations
9.
Yates, Sean G., et al.. (2022). Utilization of emicizumab in acquired hemophilia A: A case report. Transfusion and Apheresis Science. 61(6). 103457–103457. 6 indexed citations
10.
Nathwani, Amit C., Ulrike M. Reiss, Edward G. D. Tuddenham, et al.. (2018). Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer. Blood. 132(Supplement 1). 491–491. 94 indexed citations
11.
Zuo, Yu, Ravi Sarode, Song Zhang, et al.. (2018). Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers. Clinical and Applied Thrombosis/Hemostasis. 24(6). 980–985. 6 indexed citations
12.
Patel, Prapti A., et al.. (2017). A case of autoimmune severe acquired von Willebrand syndrome (type 3-like). Transfusion and Apheresis Science. 56(3). 431–433. 5 indexed citations
13.
Tanrıöver, Bekir, Ronak Lakhia, Yu‐Min Shen, et al.. (2015). Characteristics and Outcomes of Renal Transplant Recipients With Hemolytic Uremic Syndrome in the United States. Transplantation Direct. 1(10). e41–e41. 2 indexed citations
14.
Shen, Yu‐Min, et al.. (2014). Fibrinogen Dusart presenting as recurrent thromboses in the hepatic portal system. Blood Coagulation & Fibrinolysis. 25(4). 392–394. 7 indexed citations
15.
Schindler, John, Farhad Ravandi, Yu‐Min Shen, et al.. (2011). A phase I study of a combination of anti‐CD19 and anti‐CD22 immunotoxins (Combotox) in adult patients with refractory B‐lineage acute lymphoblastic leukaemia. British Journal of Haematology. 154(4). 471–476. 69 indexed citations
16.
Huang, Lily, Yu‐Min Shen, & Gamze B. Bulut. (2010). Advances in understanding the pathogenesis of primary familial and congenital polycythaemia. British Journal of Haematology. 148(6). 844–852. 25 indexed citations
17.
Shen, Yu‐Min, et al.. (2010). Delayed massive pulmonary thromboembolic phenomenon following envenomation by Mojave rattlesnake (Crotalus scutulatus). Thrombosis and Haemostasis. 104(7). 186–188. 9 indexed citations
18.
Altuntaş, Fevzi, Karén Matevosyan, James Burner, Yu‐Min Shen, & Ravi Sarode. (2008). Higher optical density of an antigen assay predicts thrombosis in patients with heparin‐induced thrombocytopenia. European Journal Of Haematology. 80(5). 429–435. 30 indexed citations
19.
Sarode, Ravi, et al.. (2005). Poor correlation of supratherapeutic international normalised ratio and vitamin K‐dependent procoagulant factor levels during warfarin therapy. British Journal of Haematology. 132(5). 604–607. 26 indexed citations
20.
Frenkel, Eugene P., Yu‐Min Shen, & Barbara Haley. (2005). The Direct Thrombin Inhibitors: Their Role and Use for Rational Anticoagulation. Hematology/Oncology Clinics of North America. 19(1). 119–145. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Bosó Breakdown of academic impact, for papers by Takakazu Higuchi Breakdown of academic impact, for papers by Josette Champagne Breakdown of academic impact, for papers by Rahul Naithani Breakdown of academic impact, for papers by Lijuan Li Breakdown of academic impact, for papers by J. F. Johnson Breakdown of academic impact, for papers by Marit Hellebostad Breakdown of academic impact, for papers by Neng Yu Breakdown of academic impact, for papers by Charlotte Bradbury Breakdown of academic impact, for papers by Ahmad Naim
Rankless by CCL
2026